We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $481M
1-Year Est. Return 35.73%
This Fund
S&P 500
This Quarter Est. Return
+17.22%
1 Year Est. Return
+35.73%
3 Year Est. Return
+116.09%
5 Year Est. Return
+167.64%
10 Year Est. Return
+1,066.43%
AUM
$397M
AUM Growth
+$54.6M
Cap. Flow
-$1.75M
Cap. Flow %
-0.44%
Top 10 Hldgs %
71.23%
Holding
50
New
2
Increased
12
Reduced
27
Closed
–

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$259K
2
DUK icon
Duke Energy
DUK
+$189K
3
TGT icon
Target
TGT
+$177K
4
NOW icon
ServiceNow
NOW
+$131K
5
NVDA icon
NVIDIA
NVDA
+$127K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$825K
2
ABBV icon
AbbVie
ABBV
+$543K
3
GILD icon
Gilead Sciences
GILD
+$409K
4
AZN icon
AstraZeneca
AZN
+$354K
5
ISRG icon
Intuitive Surgical
ISRG
+$127K

Sector Composition

Rank Sector Weight
1 Technology 42.33%
2 Consumer Discretionary 28.14%
3 Healthcare 17.65%
4 Communication Services 10.14%
5 Utilities 0.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
26
AstraZeneca
AZN
$254B
$1.56M 0.39%
11,589
-2,721
-19% -$354K
BMY icon
27
Bristol-Myers Squibb
BMY
$131B
$1.42M 0.36%
27,692
-5
-0% -$262
ABBV icon
28
AbbVie
ABBV
$462B
$1.42M 0.36%
9,157
-3,727
-29% -$543K
COST icon
29
Costco
COST
$407B
$1.12M 0.28%
1,697
-34
-2% -$20.2K
ABT icon
30
Abbott
ABT
$178B
$785K 0.2%
7,134
-182
-2% -$18.2K
MRK icon
31
Merck
MRK
$358B
$733K 0.18%
6,723
-243
-3% -$25.2K
JNJ icon
32
Johnson & Johnson
JNJ
$645B
$721K 0.18%
4,601
-100
-2% -$15.3K
BA icon
33
Boeing
BA
$165B
$683K 0.17%
2,619
-40
-2% -$8.55K
PAYX icon
34
Paychex
PAYX
$42.1B
$644K 0.16%
5,405
– –
JPM icon
35
JPMorgan Chase
JPM
$930B
$600K 0.15%
3,526
-40
-1% -$6.06K
NUE icon
36
Nucor
NUE
$57.6B
$559K 0.14%
3,210
-10
-0.3% -$1.59K
DE icon
37
Deere & Co
DE
$183B
$532K 0.13%
1,330
-10
-0.7% -$3.77K
URGN icon
38
UroGen Pharma
URGN
$2.1B
$521K 0.13%
34,701
– –
CAT icon
39
Caterpillar
CAT
$362B
$418K 0.11%
1,414
-8
-0.6% -$2.08K
BCRX icon
40
BioCryst Pharmaceuticals
BCRX
$2.1B
$339K 0.09%
56,600
– –
V icon
41
Visa
V
$702B
$271K 0.07%
1,042
-78
-7% -$19.2K
EOLS icon
42
Evolus
EOLS
$530M
$264K 0.07%
25,070
– –
ORCL icon
43
Oracle
ORCL
$415B
$252K 0.06%
2,389
– –
IDXX icon
44
Idexx Laboratories
IDXX
$40B
$234K 0.06%
422
-38
-8% -$17.8K
PFE icon
45
Pfizer
PFE
$158B
$223K 0.06%
7,755
-555
-7% -$16.8K
TGT icon
46
Target
TGT
$72.3B
$207K 0.05%
+1,450
New +$177K
DUK icon
47
Duke Energy
DUK
$92.9B
$202K 0.05%
+2,080
New +$189K
PLSE icon
48
Pulse Biosciences
PLSE
$3.91B
$126K 0.03%
10,325
– –
SMMT icon
49
Summit Therapeutics
SMMT
$14.8B
$62.8K 0.02%
24,059
– –
CMRX
50
DELISTED
Chimerix, Inc.
CMRX
$10.2K ﹤0.01%
10,609
– –
1
2

Similar funds

MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
WAS
Winch Advisory Services Appleton, Wisconsin $481M AUM 22.61% 1-Year Est. Return
SA
Stewardship Advisors Mount Joy, Pennsylvania $481M AUM 18.41% 1-Year Est. Return
NC
NovaPoint Capital Atlanta, Georgia $481M AUM 32.01% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $481M AUM 20.5% 1-Year Est. Return
MAV
Mason & Associates (Virginia) Newport News, Virginia $481M AUM 12.85% 1-Year Est. Return
OMIC
Old Mission Investment Co Traverse City, Michigan $481M AUM
SCA
Sage Capital Advisors Sioux Falls, South Dakota $482M AUM 34.73% 1-Year Est. Return

Bender Robert & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Bender Robert & Associates held 50 positions worth $397M, up 16% from $342M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 4%. Bender Robert & Associates opened 2 new positions and made no exits, leaving the 50-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's largest Q4 2023 buy was Duke Energy: 2,080 shares worth $202K.
  • Bender Robert & Associates added most to Palo Alto Networks in Q4 2023, an estimated $259K increase.
  • Bender Robert & Associates's biggest Q4 2023 reduction was Apple, cutting an estimated $825K.
  • Bender Robert & Associates's ten largest holdings make up 71% of its $397M portfolio in Q4 2023.
  • Bender Robert & Associates opened 2 new positions and closed 0 in Q4 2023.
  • Bender Robert & Associates's portfolio value rose 16% quarter-over-quarter to $397M.

Based on Bender Robert & Associates's 13F filing for Q4 2023, filed 31 Jan 2024.